Consolidated Statements of Changes in Stockholders' Equity - USD ($)		Total	Convertible Notes Payable Convertible Debt	Warrant Issued For Vessel Consideration	Common Stock		Common Stock Convertible Notes Payable Convertible Debt	Common Stock Warrant Issued For Vessel Consideration		Additional paid-in capital		Additional paid-in capital Convertible Notes Payable Convertible Debt	[1]	Additional paid-in capital Warrant Issued For Vessel Consideration	[1]	Accumulated Deficit	Accumulated other comprehensive income/(loss)
Beginning balance (in shares) at Dec. 31, 2018	[1]				10,150,771
Beginning balance at Dec. 31, 2018		$ 479,605,849			$ 101,508	[1]				$ 894,881,580	[1]					$ (415,377,239)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(21,697,115)														(21,697,115)
Proceeds received from the Share Lending Agreement		35,829								35,829	[1]
Issuance of shares due to vesting of restricted shares (in shares)	[1]				63,829
Issuance of shares due to vesting of restricted shares	[1]				$ 638					(638)
Equity component of Convertible Bond Debt, net of equity issuance costs	[1]									20,175,803
Equity component of Convertible Bond Debt, net of equity issuance costs		20,175,803
Cash used to settle net share equity awards		(1,443,753)								(1,443,753)	[1]
Unrealized gain on cash flow hedges		0
Stock-based compensation		4,826,324								4,826,324	[1]
Ending balance (in shares) at Dec. 31, 2019	[1]				10,214,600
Ending balance at Dec. 31, 2019		481,502,937			$ 102,146	[1]				918,475,145	[1]					(437,074,354)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(35,063,468)														(35,063,468)
Issuance of shares due to vesting of restricted shares (in shares)	[1]				65,982
Issuance of shares due to vesting of restricted shares	[1]				$ 660					(660)
Cash used to settle net share equity awards		(1,162,609)								(1,162,609)	[1]
Issuance of common shares for equity offering (in shares)	[1]				1,381,215
Issuance of common shares for equity offering		23,817,505			$ 13,812	[1]				23,803,693	[1]
Fees for Equity Offerings		(579,651)								(579,651)	[1]
Cash used to settle fractional shares in the Reverse Stock Split		(12,513)								(12,513)	[1]
Unrealized gain on cash flow hedges		(1,132,398)															(1,132,398)
Stock-based compensation		3,048,280								3,048,280	[1]
Ending balance (in shares) at Dec. 31, 2020	[1]				11,661,797
Ending balance at Dec. 31, 2020		470,418,083			$ 116,618	[1]				943,571,685	[1]					(472,137,822)	(1,132,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		184,897,884														184,897,884
Dividends		(26,254,860)														(26,254,860)
Issuance of shares due to vesting of restricted shares (in shares)	[1]				81,281
Issuance of shares due to vesting of restricted shares		0			$ 813	[1]				(813)	[1]
Issuance of shares upon exercise of stock options (in shares)	[1]				50,641
Options vested and exercised		55,578			$ 506	[1]				55,072	[1]
Cash used to settle net share equity awards		(1,936,581)								(1,936,581)	[1]
Issuance of common shares for equity offering (in shares)	[1]				581,385
Issuance of common shares for equity offering		27,138,338			$ 5,814	[1]				27,132,524	[1]
Issuance of shares upon conversion (in shares)	[1]						25	541,898
Issuance of shares upon conversion			$ 982	$ 10,679,988				$ 5,419	[1]			$ 982		$ 10,674,569
Fees for Equity Offerings		(232,971)								(232,971)	[1]
Unrealized gain on cash flow hedges		3,018,683															3,018,683
Stock-based compensation		3,481,095								3,481,095	[1]
Ending balance (in shares) at Dec. 31, 2021	[1]				12,917,027
Ending balance at Dec. 31, 2021		$ 671,266,219			$ 129,170	[1]				$ 982,745,562	[1]					$ (313,494,798)	$ 1,886,285

[1] * Adjusted retroactively to give effect for the 1-for-7 Reverse Stock Split that became effective as of September 15, 2020, see Note 1, General Information.